Amedisys Reports Fourth Quarter and Year End 2021 Financial Results; Issues 2022 ... | https://www.globenewswire.com/news-release/2022/02/23/2390753/30555/en/Amedisys-R... | Amedisys, Inc. | https://www.globenewswire.com/en/search/organization/Amedisysδ%2520Inc§?page=1 | BATON ROUGE, La., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED)... | |
Source:
Amedisys, Inc. | Amedisys Reports Fourth Quarter and Year End 2021 Financial Results; Issues 2022 ... | |
Source:
Amedisys, Inc. | | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC |
GBT Reports Fourth Quarter and Full Year 2021 Financial Results | https://www.globenewswire.com/news-release/2022/02/23/2390750/37049/en/GBT-Report... | Global Blood Therapeutics, Inc. | https://www.globenewswire.com/en/search/organization/Global%2520Blood%2520Therape... | Achieved Oxbryta® (voxelotor) net revenues of $56.1 million in the fourth quarter... | |
Source:
Global Blood Therapeutics, Inc. | GBT Reports Fourth Quarter and Full Year 2021 Financial Results | |
Source:
Global Blood Therapeutics, Inc. | | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC |
Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results | https://www.globenewswire.com/news-release/2022/02/23/2390798/0/en/Nephros-Announ... | Nephros, Inc. | https://www.globenewswire.com/en/search/organization/Nephrosδ%2520Inc§?page=1 | Reports Full-Year Net Revenue of $10.4 Million, a 22% Year-Over-Year Increase and... | |
Source:
Nephros, Inc. | Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results | |
Source:
Nephros, Inc. | | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC |
OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Productio... | https://www.globenewswire.com/news-release/2022/02/23/2390758/11732/en/OraSure-Te... | OraSure Technologies, Inc. | https://www.globenewswire.com/en/search/organization/OraSure%2520Technologiesδ%25... | Total 2021 revenue of $233.7 million, up 36% year-over year InteliSwab® receives ... | |
Source:
OraSure Technologies, Inc. | OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Productio... | |
Source:
OraSure Technologies, Inc. | | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC |
Orphazyme announces update on regulatory review of arimoclomol in the European Un... | https://www.globenewswire.com/news-release/2022/02/23/2390752/0/en/Orphazyme-anno... | ORPHAZYME A/S | https://www.globenewswire.com/en/search/organization/ORPHAZYME%2520A%252FS?page=1... | Orphazyme A/SCompany announcementNo. 07/2022Inside informationwww.orphazyme.comCo... | |
Source:
ORPHAZYME A/S | Orphazyme announces update on regulatory review of arimoclomol in the European Un... | |
Source:
ORPHAZYME A/S | | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC |
RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on ... | https://www.globenewswire.com/news-release/2022/02/23/2390782/0/en/RxSight-Inc-to... | RxSight, Inc. | https://www.globenewswire.com/en/search/organization/RxSightδ%2520Inc§?page=1 | ALISO VIEJO, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, ... | |
Source:
RxSight, Inc. | RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on ... | |
Source:
RxSight, Inc. | | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC |
Singular Genomics Systems, Inc. to Report Fourth Quarter and Full Year 2021 Finan... | https://www.globenewswire.com/news-release/2022/02/23/2390806/0/en/Singular-Genom... | Singular Genomics Systems, Inc. | https://www.globenewswire.com/en/search/organization/Singular%2520Genomics%2520Sy... | LA JOLLA, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, In... | |
Source:
Singular Genomics Systems, Inc. | Singular Genomics Systems, Inc. to Report Fourth Quarter and Full Year 2021 Finan... | |
Source:
Singular Genomics Systems, Inc. | | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC |
The RECELL® System Receives PMDA Approval in Japan and AVITA Medical will Commerc... | https://www.globenewswire.com/news-release/2022/02/23/2390815/0/en/The-RECELL-Sys... | AVITA Medical | https://www.globenewswire.com/en/search/organization/AVITA%2520Medical?page=1 | VALENCIA, Calif. and MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- AVIT... | |
Source:
AVITA Medical | The RECELL® System Receives PMDA Approval in Japan and AVITA Medical will Commerc... | |
Source:
AVITA Medical | | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC |
Treace Highlights New Product Innovations at the 2022 ACFAS Scientific Conference... | https://www.globenewswire.com/news-release/2022/02/23/2390794/0/en/Treace-Highlig... | Treace Medical Concepts, Inc. | https://www.globenewswire.com/en/search/organization/Treace%2520Medical%2520Conce... | PONTE VEDRA, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc... | |
Source:
Treace Medical Concepts, Inc. | Treace Highlights New Product Innovations at the 2022 ACFAS Scientific Conference... | |
Source:
Treace Medical Concepts, Inc. | | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC |
Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-24 fo... | https://www.globenewswire.com/news-release/2022/02/23/2390751/0/en/Vaxcyte-Doses-... | Vaxcyte, Inc. | https://www.globenewswire.com/en/search/organization/Vaxcyteδ%2520Inc§?page=1 | -- Company Expects to Announce Topline Results from the Phase 1/2 Study by the En... | |
Source:
Vaxcyte, Inc. | Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-24 fo... | |
Source:
Vaxcyte, Inc. | | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | https://www.globenewswire.com/search/industry/health%2520care%2chealth%2520care%2... | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC | 2022-02-24 09:38:35 UTC |